CLINICAL_TRIALS
trial_result
· 2025-12-30
Clinical Trial Update: Contrast-enhanced Ultrasound for Sentinel Node Detection [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 clinical trial sponsored by The Netherlands Cancer Institute is evaluating contrast-enhanced ultrasound for sentinel lymph node detection in m…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: The Netherlands Cancer Institute | Conditions: Melanoma, Breast Cancer | Phase 2, Phase 3 | Status: RECRUITING